Urinary Incontinence: Clinical Trials

5 trials for Urinary Incontinence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 5
Phase 31Terminated 1

Follow Urinary Incontinence: new trials by email Literature Review of Urinary Incontinence trials Research Report on Urinary Incontinence

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder
Bryophyllum - Overactive Bladder, Urge Urinary Incontinence
Phase 2 / Phase 3TerminatedUniversity of Zurich92014-05-012017-10-26
ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)
ELB245, Tolterodine - Overactive Bladder, Urinary Incontinence
Phase 2Terminatedelbion AG2752007-02-012007-08-08
Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity
AV608 - Overactive Bladder Syndrome
Phase 2TerminatedAvera Pharmaceuticals622006-06-012008-02-25
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
GW679769 - Incontinence, Urinary and Urinary Bladder, Overactive, Overactive Bladder
Phase 2TerminatedGlaxoSmithKline12006-01-012015-04-17
Effect of Pelvic Floor Muscle Training in Stroke
Pelvic Floor Muscle training - Stroke, Urinary Incontinence
Phase 2TerminatedGlostrup University Hospital, Copenhagen601999-01-012010-05-26

Narrower conditions

Urinary Bladder, Overactive (4)  ·  Urinary Incontinence, Urge (3)  ·  Spinal Cord Injuries (1)  ·  Stroke (1)

Broader conditions

Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Lower Urinary Tract Symptoms (5)  ·  Male Urogenital Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Urination Disorders (5)  ·  Urogenital Diseases (5)  ·  Urologic Diseases (5)  ·  Urological Manifestations (5)  ·  Urinary Bladder Diseases (4)  ·  Central Nervous System Diseases (2)  ·  Nervous System Diseases (2)  ·  Brain Diseases (1)

Interventions

Tolterodine Tartrate (1)  ·  casopitant (1)

Sponsors

Avera Pharmaceuticals (1)  ·  GlaxoSmithKline (1)  ·  Glostrup University Hospital, Copenhagen (1)  ·  University of Zurich (1)  ·  elbion AG (1)

Countries

Denmark (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Joao Siffert, MD (1)  ·  Linda Cardozo, MD FRCOG (1)  ·  Martin Michel, Prof. (1)  ·  Sigrid G Tibaek, MSc., Pt (1)

Results publications

PMID 15014939, PMID 15791633, PMID 16673051, PMID 23218404, PMID 34988092